Prevalence of hepatitis B, Hepatitis C and HIV among injecting drug users treated outpatiently and in therapeutic community in Brod-Posavina County, Croatia;Usporedba Prevalencije Biljega Hepatitisa B, C I HIV-A Medu Intravenskim Ovisnicima Liječenima Ambulantno I U Terapijskoj Zajednici na Području Brodsko-Posavske Županije

Acta Medica Croatica

Volumn 64, Issue 4, 2010, Pages 287-296

  Kolovrat, A ^a   Jurisic I ^a   Maric Z ^a   Cvitkovic A ^a  

^a Institute of Public Health   (Croatia)

Author keywords

Brod Posavina County; HBV; HCV; HIV; Injection drug users

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CROATIA; DISEASE TRANSMISSION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; PREVALENCE; SUBSTANCE ABUSE; VIROLOGY;

ADOLESCENT; ADULT; CROATIA; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 79960077513     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mohammadi M., Talei G., Sheikhian A i sur. Survey of both hepatitis B virus (HBsAg) and hepatitis C virus (HCV-Ab) coinfection among HIV positive patients. Virol J (časopis na internetu) 2009; Dostupno na URL adresi: http://www.virologyj.com/content/6/1/202. Datum pristupa informaciji 20. prosinac 2009.
2. Mulić R, Uglešić L, Klišmanić Z i sur. Epidemiološke karakteristike hepatitisa B u Splitsko-dalmatinskoj županiji. Lijec Vjesn 2006; 128: 65-71. (Pubitemid 43759281)
3. Wiessing L, Guarita B., Giraudon I., Brumer- Korvenkontio H., Salminen M., Cowan MS. Europian monitoring of notifications of hepatitis C virus infection in the general population and among injecting drug users (IDUs)- the need to improve quality and comparability. Euro Surveill (časopis na internetu) 2008; Dostupno na URL adresi: http://www.eurosurveillance.org/ WievArticle. aspx?ArzicleId=18884. Datum pristupa informaciji 20. prosinac 2009.
4. Seme K, Luner MM, Tomazić J i sur. Low prevalence of hepatitis B and C infections among HIVinfected individuals in Slovenia: a nation wide study, 1986-2008. Acta Dermatovenerol APA 2009; 18: 153-6.
5. Merja Rantala, van de Larr MJ. Surveillance and epidemiology of hepatitis B and C in Europe - a review. Euro Surveill 2008; 13: 194-201.
6. Vucelić B, Hrstić I, Begovac J i sur. Virusni hepatitis: Hrvatske konsenzus konferencija. Acta Med Croatica 2005; 59: 359-75. (Pubitemid 41807678)
7. Vrhovac B, Francetić I, Jakšić B, Labar B, Vucelić B. Interna medicina. Zagreb: Naklada ljevak, 2003, 926-30.
8. Jimanez AP, Mohamed MK, Eldin NS i sur. Injection drug use is a risk factor for HCV infection in urban Egypt. PLoS One (časopis na internetu) 2009; dostupno na URL adresi: http://www.ncbi.nlm.nih. gov/pmc/articles/ PMC2745657/?tool=pubmed. Datum pristupa informaciji 10. prosinac 2009.
9. Santana Rodriguez OE, Malé Gil ML, Hernández Santana JF, Limiňana Caňal JM, Martin Sánchez AM. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol 1998; 14: 555-61. (Pubitemid 28439590)
10. Lobstein R, Mahagna R, Maor Y i sur. Hepatitis C, B and human immunodeficiency virus infections in illict drug users in Israel: prevalence and risk factors. Isr Med Assoc J 2008; 10: 775-8.
11. Clatts MC, Colón-López V., Giang LM, Goldsamt LA. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. J Urban Health (časopis na internetu) 2009. Dostupno na URL adresi: Http://www.springerlink. com/content/611xp18361378hn/. Datum pristupa informaciji 10. siječanj 2010.
12. Hepatitis B/C and HIV Prevalence in Injecting Drug Users in Ukraine. Dostupno na URL adresi: www. euro.who.int/document/SHA/hepatitis-b-c.pdf. Datum pristupa informaciji 22. prosinca 2009.
13. Uusküla A, Kals M, Rajaleid K i sur. Highprevalence and high-estimated incidence of HIV infection among new injecting users in Estonia: need for large scale prevention program. J Public Health (Oxf) 2008; 30: 119- 25.
14. Khin Pyone Kyi, Myo Aye, Khin May Oo i sur. Prevalence of hepatitis C in healthy population and patients with liver ailments in Myanmar. Regional Health Forum (časopis na internetu) 2002. Dostupno na URL adresi: http://www.searo. who.int/en/Section1243/Section1310/Section1344/Section1355- 5303.htm. Datum pristupa informaciji 25. prosinac 2009.
15. Anonimo. Izvješće o osobama liječenim zbog zlouporabe psihoaktivnih droga u Hrvatskoj u 2008. godini, Zagreb: Hrvatski zavod za javno zdravstvo, Ministarstvo zdravstva i socijalne skrbi Republike Hrvatske, 2009.
16. Vazarian M, Nassirimanesh B, Zamani S, Ono- Kihara M, Ravari SM, Gouya MM. Needle and syringe sharing practices of injecting drugs users partipating in outeeach HIV prevention program in Teheran, Iran: a cross-sectional study. Harm Reduct J (časopis na internetu) 2005. Dostupno na URL adresi: http://www.ncbi.nlm. nih.gov/pcm/articles/PMC2806876/?tool=pubmed. Datum pristupa informaciji 21. prosinca 2009.
17. Hahn JA, Page-Shafer K, Ford J, Paciorek A, Lum PJ. Traveling young injection drug users at high risk for acquisition and transmission of viral infections. Drug Alcohol Depend 2008; 93: 43-50. (Pubitemid 350236588)
18. Anonimo. Hrvatski zdravstveni statistički ljetopis za 2008. godinu. Zagreb: Hrvatski zavod za javno zdravstvo, 2009.
19. Harm reduction. Dostupno na URL adresi: http://www.droge.hr/harm.html Datum pristupanja informaciji 14. prosinca 2009.
20. Harm reduction pristup. Dostupno na URL adresi: www.spica-info.hr/conect. php?a-id89. Datum pristupa informaciji 18. siječnja 2010.
21. Harm reduction: politika smanjenja štete. Dostupno na URL adresi: www.moravek.net/ovisnosti/200401/harm-reduction.html. Datum pristupa informaciji 25. prosinca 2009.
22. Cijepljenje protiv hepatitisa B. Dostupno na URL adresi: http://www.cybermed.hr/index.php/pbl/portal -za-pacijente/centri-za-edukaciju/ cjepiva/cijepljenje- protiv-hepatitisa-b. Datum pristupa informaciji 25. prosinca 2009.
23. Morsica G, Ancarani F, Bagaglio S i sur. Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological featurs. Infection 2009; 37: 445-9.
24. Falster K, Kaldor JM, Maher L i sur. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004. J Urban Health 2009 ; 86: 106-18.
25. Medić A, Dzelalija B, Sonicki Z, Zekanović D. Characteristics of hepatitis C infection in injecting drug users iz Zadar County, Croatia. Coll Antropol 2008; 32: 697-702.
26. Scheinman R, Hagan H, Lelutiu-Weinberger C i sur. Non-injection drug users and hepatitis C virus: a sistematic review. Drug Alcohol Depend 2007; 89: 1-12. (Pubitemid 46602869)
27. Deri KhS, Singh NB, Singh HL, Singh YM. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users. J Indian Med Assoc 2009; 107: 144, 146-7.